Human Subject Research and Blood Sampling: Lessons from the Kaplan Medical Center Report

We are pleased to share our latest client update on human subject research and blood sampling in Israel.

Recent media reports concerning Kaplan Medical Center have raised questions about the use of patient blood samples in research and informed consent. While the circumstances remain unclear, the reports provide a timely opportunity to consider how sponsors and companies can help ensure that research approvals, consent documents, and site practices are aligned.

Our update discusses key considerations for research conducted with Israeli hospitals, including study classification, approval and consent requirements, sample collection and use, and sponsor oversight.

As always, the team at Agmon with Tulchinsky remains at your disposal